pantoprazole has been researched along with Eosinophilia, Tropical in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The development of eosinophilic gastritis immediately after Helicobacter pylori eradication has not previously been described: A 62-year-old woman developed eosinophilic gastritis immediately after a triple therapy for Helicobacter pylori eradication, consisting of pantoprazole, amoxicillin and clarithromycin." | 3.74 | [Eosinophilic gastritis after helicobacter pylori eradication]. ( Aigner, T; Fritzsch, J; Krügel, V; Pluta, L; Schütz, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wauters, L | 1 |
| Ceulemans, M | 1 |
| Frings, D | 1 |
| Lambaerts, M | 1 |
| Accarie, A | 1 |
| Toth, J | 1 |
| Mols, R | 1 |
| Augustijns, P | 1 |
| De Hertogh, G | 1 |
| Van Oudenhove, L | 1 |
| Tack, J | 1 |
| Vanuytsel, T | 1 |
| Fritzsch, J | 1 |
| Krügel, V | 1 |
| Aigner, T | 1 |
| Pluta, L | 1 |
| Schütz, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Proton Pump Inhibitors on the Duodenal Microbiome in Healthy Volunteers and Functional Dyspepsia Patients[NCT03545243] | Phase 4 | 79 participants (Actual) | Interventional | 2018-04-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for pantoprazole and Eosinophilia, Tropical
| Article | Year |
|---|---|
Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
Topics: Adult; Belgium; Bile Acids and Salts; Case-Control Studies; Duodenal Diseases; Duodenum; Dyspepsia; | 2021 |
[Eosinophilic gastritis after helicobacter pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biop | 2008 |